Digest Network Come funziona
Network
/
Società
Mo
Non verificato

MolecuLight Inc.

Di cosa scriviamo

EconomiaFarmaceuticaFinanzaSanitàScienza

18 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
10/07/2025
Salute
Fitness
Medicina - Varie
MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
04/06/2025
Farmaceutica
Sanità
Finanza
MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
30/04/2025
Farmaceutica
Sanità
Economia
Start-up
MolecuLight Unveils Thermal Imaging for DX(TM) Platform, Delivering Measurement, Bacterial & Thermal Assessment in One Device, and Showcases Clinical Evidence at SAWC Spring
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
29/04/2025
Farmaceutica
Sanità
MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
08/04/2025
Farmaceutica
Sanità
MolecuLight Optimizes Burn Care with Advanced Bacterial Imaging at the American Burn Association 2025 Annual Meeting
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
03/04/2025
Farmaceutica
Sanità
Scienza
Study Links Bacterial Load to Pain in Venous Ulcers, Demonstrating Effective Reduction with MolecuLight
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
28/02/2025
Farmaceutica
Sanità
Finanza
MolecuLight Showcases Advanced Wound Care Imaging at 2025 CAMPS Meeting
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
Press Release cover image
28/01/2025
Farmaceutica
Sanità
Finanza
MolecuLight Announces Presentation of its Clinical and Surgical Benefits in Reconstructive Plastic Surgery by Dr. Michael Desvigne at the 47th Annual JAB Maui Burn & Wound Symposium
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
Press Release cover image
06/01/2025
Farmaceutica
Sanità
MolecuLight Secures $27.5 Million From Hayfin, a Leading Healthcare Institutional Investor
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0
Press Release cover image
18/11/2024
Farmaceutica
Sanità
Economia
Start-up
MolecuLight® Applauds New CMS Local Coverage Determination (LCD) Changes for Skin Substitutes
Fonte
MolecuLight Inc.
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0